Children and Adolescents - Ongoing Studies - Texas Diabetes Institute

Ongoing Studies

Type 1 diabetes

A Phase III, 3-Arm, Randomized, Double Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus, IRB#HSC20090153H. Principal Investigator: William M. Rogers, MD - 210-704-4443.
Early Detection of Blood Vessel Abnormalities in Children with Diabetes. IRB# 034-9000-243. Principal Investigator: Daniel E. Hale, MD (210) 358-7586.

Type 2 diabetes

Early Detection of Blood Vessel Abnormalities in Children with Diabetes. IRB# 034-9000-243. Principal Investigator: Daniel E. Hale, MD (210) 358-7586.
Treatment Options for Type 2 Diabetes in Adolescents and Youth Genetics Study. IRB# 20090028H. Principal Investigator: Jane Lynch, MD. 210-358-7550.

Other

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes. IRB#: HSC20080343H, Prinicipal Investigator: Jane Lynch, MD (210) 358-7550.
TrailNet: Natural History Study of the Development of Type 1 Diabetes IRB# 20060084H. Principal Investigator: Daniel Hale, MD (210) 358-7586.
Type 1 Diabetes Genetics Consortium IRB#HSC 20070255H. Principal Investigator: Daniel Hale, MD (210) 358-7586.
The San Antonio Family Assessment of Metabolic Risk Indicators in Youth. IRB# 045-0024-092 No UHS number. Principal Investigator: R. Duggirala (210) 358-7550. Currently recruiting from parents who previously participated in the San Antonio Family Heart Study, the San Antonio Family Diabetes or Gallbladder Study or the Veterans Administration Genetic Epidemiology Study.
Early Detection of Blood Vessel Abnormalities in Children with Diabetes. IRB# 034-9000-243. Principal Investigator: Daniel E. Hale, MD (210) 358-7586.
Prevalence and Progression of Type 2 Diabetes Mellitus in Mexican American Youth. IRB# 990-9000-456. Principal Investigator: Daniel Hale, MD (210) 358-7550.
Norditropin in Children with Growth Failure Associated with IGF Deficiency: A 12- month, open-label, Randomized, Parallel Group Study. IRB# 023-9000-148. Principal Investigator: Daniel Hale, MD-(210) 358-7550.
The Metabolic Syndrome in Mexican American Children. IRB#
045-0024-092. Principal Investigator: Ravindranath Duggirala, PhD - (210) 358-7550.